1. Home
  2. SURG vs ANL Comparison

SURG vs ANL Comparison

Compare SURG & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

N/A

Current Price

$0.78

Market Cap

18.3M

ML Signal

N/A

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

N/A

Current Price

$9.07

Market Cap

350.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SURG
ANL
Founded
2006
2004
Country
United States
Cayman Islands
Employees
20
N/A
Industry
Advertising
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
18.3M
350.9M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
SURG
ANL
Price
$0.78
$9.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$9.75
$16.00
AVG Volume (30 Days)
166.4K
218.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.78
N/A
Revenue Next Year
$113.46
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.75
$0.88
52 Week High
$3.47
$12.09

Technical Indicators

Market Signals
Indicator
SURG
ANL
Relative Strength Index (RSI) 33.42 57.38
Support Level $0.75 $1.37
Resistance Level $0.95 $10.15
Average True Range (ATR) 0.06 0.92
MACD 0.03 -0.32
Stochastic Oscillator 20.96 60.88

Price Performance

Historical Comparison
SURG
ANL

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: